• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Focus on infection and sepsis in intensive care patients.

作者信息

Martin-Loeches Ignacio, Perner Anders

机构信息

Multidisciplinary Intensive Care Research Organization (MICRO), Department of Clinical Medicine, Trinity Centre for Health Sciences. The Wellcome Trust - HRB Dublin Centre for Clinical Research (DCCR), St James's University Hospital, James's Street, Dublin 8, Ireland.

CIBER Enfermedades Respiratorias (CIBERES), Barcelona, Spain.

出版信息

Intensive Care Med. 2016 Apr;42(4):491-493. doi: 10.1007/s00134-016-4234-6. Epub 2016 Feb 9.

DOI:10.1007/s00134-016-4234-6
PMID:26862017
Abstract
摘要

相似文献

1
Focus on infection and sepsis in intensive care patients.关注重症监护患者的感染与脓毒症。
Intensive Care Med. 2016 Apr;42(4):491-493. doi: 10.1007/s00134-016-4234-6. Epub 2016 Feb 9.
2
Interpreting Laboratory Tests in Infection: Making Sense of Biomarkers in Sepsis and Systemic Inflammatory Response Syndrome for Intensive Care Unit Patients.解读感染中的实验室检查：理解重症监护病房患者脓毒症和全身炎症反应综合征中的生物标志物
Crit Care Nurs Clin North Am. 2017 Mar;29(1):119-130. doi: 10.1016/j.cnc.2016.09.004. Epub 2016 Dec 14.
3
[The septic disease picture from the viewpoint of the internal medicine intensive care physician].[从内科重症监护医师角度看败血症病情]
Beitr Infusionther Klin Ernahr. 1983;10:8-16.
4
Severe sepsis and its impact on outcome in elderly and very elderly patients admitted in intensive care unit.严重脓毒症及其对入住重症监护病房的老年和非常老年患者预后的影响。
J Intensive Care Med. 2012 May-Jun;27(3):179-83. doi: 10.1177/0885066610397116. Epub 2011 Mar 24.
5
Bibliography. Current world literature. Infectious diseases.参考文献。当代世界文献。传染病。
Curr Opin Crit Care. 2006 Oct;12(5):517-26.
6
Keep your eyes on sepsis.密切关注败血症。
Crit Care Nurse. 2012 Dec;32(6):74-5. doi: 10.4037/ccn2012221.
7
Does albumin fluid resuscitation in sepsis save lives?脓毒症中白蛋白液体复苏能挽救生命吗？
Crit Care Med. 2011 Feb;39(2):418-9. doi: 10.1097/CCM.0b013e318206b0ff.
8
Practice and perception--a nationwide survey of therapy habits in sepsis.实践与认知——一项关于脓毒症治疗习惯的全国性调查
Crit Care Med. 2008 Oct;36(10):2719-25. doi: 10.1097/CCM.0b013e318186b6f3.
9
Sex-dependent disparities in critical illness: methodological implications for critical care research.危重病中的性别差异：危重症护理研究的方法学意义
Nurs Crit Care. 2015 Mar;20(2):58-62. doi: 10.1111/nicc.12166.
10
Year in review 2013: Critical Care--sepsis.2013年回顾：重症监护——脓毒症
Crit Care. 2014 Oct 15;18(5):578. doi: 10.1186/s13054-014-0578-x.

引用本文的文献

1
The protagonist of contemporary and emerging nanotechnology-based theranostics and therapeutic approaches in reshaping intensive care unit.基于当代和新兴纳米技术的治疗学和治疗方法的主角正在重塑重症监护病房。
Saudi Med J. 2024 Aug;45(8):759-770. doi: 10.15537/smj.2024.45.8.20240069.
2
2030: will we still need our microbiologist?2030年：我们还需要微生物学家吗？
Intensive Care Med. 2023 Oct;49(10):1232-1234. doi: 10.1007/s00134-023-07186-6. Epub 2023 Aug 22.
3
The role of nanotechnology-based approaches for clinical infectious diseases and public health.

本文引用的文献

1
Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis.降钙素原 (PCT) 水平对 ICU 流感患者合并细菌感染的排除诊断：CHAID 决策树分析。
J Infect. 2016 Feb;72(2):143-51. doi: 10.1016/j.jinf.2015.11.007. Epub 2015 Dec 15.
2
Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study.呼吸机相关性气管支气管炎（TAVeM）的发生率和预后：一项多中心、前瞻性、观察性研究。
Lancet Respir Med. 2015 Nov;3(11):859-68. doi: 10.1016/S2213-2600(15)00326-4. Epub 2015 Oct 22.
3
Tumor necrosis factor receptor 1 (TNFRI) for ventilator-associated pneumonia diagnosis by cytokine multiplex analysis.
基于纳米技术的方法在临床传染病和公共卫生中的作用。
Front Bioeng Biotechnol. 2023 Apr 3;11:1146252. doi: 10.3389/fbioe.2023.1146252. eCollection 2023.
4
Characteristics, risk factors, and outcomes of bloodstream infections in the intensive care unit: a retrospective cohort study.重症监护病房血流感染的特征、危险因素和结局：一项回顾性队列研究。
J Int Med Res. 2023 Jan;51(1):3000605221131122. doi: 10.1177/03000605221131122.
5
SEPSIS DEFINITION: WHAT'S NEW 
IN THE TREATMENT GUIDELINES.脓毒症定义：治疗指南中的新进展。
Acta Clin Croat. 2022 Jun;61(Suppl 1):67-72. doi: 10.20471/acc.2022.61.s1.11.
6
Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China.危重症患者念珠菌血症的流行病学、物种分布、抗真菌药敏性和死亡危险因素：2011 年至 2017 年中国一家教学医院的回顾性研究。
Antimicrob Resist Infect Control. 2019 May 29;8:89. doi: 10.1186/s13756-019-0534-2. eCollection 2019.
7
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.ESICM/ESCMID 工作组关于危重症患者侵袭性念珠菌感染的实际管理。
Intensive Care Med. 2019 Jun;45(6):789-805. doi: 10.1007/s00134-019-05599-w. Epub 2019 Mar 25.
8
Surviving sepsis campaign: research priorities for sepsis and septic shock.拯救脓毒症运动：脓毒症和脓毒性休克的研究重点。
Intensive Care Med. 2018 Sep;44(9):1400-1426. doi: 10.1007/s00134-018-5175-z. Epub 2018 Jul 3.
9
ARDS: challenges in patient care and frontiers in research.急性呼吸窘迫综合征：患者护理的挑战与研究的前沿。
Eur Respir Rev. 2018 Jan 24;27(147). doi: 10.1183/16000617.0107-2017. Print 2018 Mar 31.
10
Intensive care medicine in 2050: nanotechnology. Emerging technologies and approaches and their impact on critical care.2050年的重症医学：纳米技术。新兴技术与方法及其对危重症护理的影响。
Intensive Care Med. 2018 Aug;44(8):1299-1301. doi: 10.1007/s00134-017-5002-y. Epub 2017 Nov 24.
通过细胞因子多重分析利用肿瘤坏死因子受体1（TNFRI）诊断呼吸机相关性肺炎。
Intensive Care Med Exp. 2015 Dec;3(1):26. doi: 10.1186/s40635-015-0062-1. Epub 2015 Sep 16.
4
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.抗真菌药物降级治疗与接受侵袭性念珠菌病治疗的危重症患者的不良结局无关：AmarCAND2 研究数据的事后分析。
Intensive Care Med. 2015 Nov;41(11):1931-40. doi: 10.1007/s00134-015-4053-1. Epub 2015 Sep 14.
5
Impact of Candida spp. isolation in the respiratory tract in patients with intensive care unit-acquired pneumonia.念珠菌属在重症监护病房获得性肺炎患者呼吸道中的分离情况的影响
Clin Microbiol Infect. 2016 Jan;22(1):94.e1-94.e8. doi: 10.1016/j.cmi.2015.09.002. Epub 2015 Sep 12.
6
Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.在重症监护环境中，使用生物标志物与临床决策来决定抗生素的开始和停止时的利弊。
Intensive Care Med. 2015 Oct;41(10):1739-51. doi: 10.1007/s00134-015-3978-8. Epub 2015 Jul 21.
7
β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.β-D-葡聚糖和白念珠菌芽管抗体在 ICU 侵袭性念珠菌病患者中的应用。
Intensive Care Med. 2015 Aug;41(8):1424-32. doi: 10.1007/s00134-015-3922-y. Epub 2015 Jul 2.
8
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality.多中心多国研究的腹​​腔念珠菌病：流行病学，结局和死亡率的预测因素。
Intensive Care Med. 2015 Sep;41(9):1601-10. doi: 10.1007/s00134-015-3866-2. Epub 2015 May 19.
9
Outcomes associated with routine systemic antifungal therapy in critically ill patients with Candida colonization.与危重症患者念珠菌定植患者常规全身抗真菌治疗相关的结局。
Intensive Care Med. 2015 Jun;41(6):1077-88. doi: 10.1007/s00134-015-3791-4. Epub 2015 Apr 18.
10
Incidence, characteristics and outcome of ICU-acquired candidemia in India.印度 ICU 获得性念珠菌血症的发生率、特征和结局。
Intensive Care Med. 2015 Feb;41(2):285-95. doi: 10.1007/s00134-014-3603-2. Epub 2014 Dec 16.